Octreotide acetate HY-17365 from MedChemExpress

Product Specs
ItemOctreotide acetate
CompanyMedChemExpress
Price $38.00Supplier Page View Company Product Page
Catalog NumberHY-17365
Size5 mg
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.97%
TypeChemical
Research AreaInflammation/Immunology; Endocrinology; Cardiovascular Disease; Cancer

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Sidt2 inhibits islet β-cell dedifferentiation by regulating insulin secretionJournal of Biological ChemistrySeptember 1, 2025Jing Gu, Meng-Xiang Qi, Rui-Xi Zhang, Ying-Ying Song, Xing Hu, Hai-Jun Liu, Ya-Ting Zhang, Wen-Xiu Wu, Ya-Jun Wu, Jia-Hao Xu, et al.(GM) treatments INS-1 cells were cultured in RPMI 1640 medium with 0 to 100 mg/L octreotide acetate (Hy-17365, MedChemExpress) for 0 to 48 h. The supernatant was collected, and the insulin content was measured

(2) Combining [(177)Lu]Lu-DOTA-TOC PRRT with PARP inhibitors to enhance treatment efficacy in small cell lung cancerEuropean journal of nuclear medicine and molecular imagingNovember 1, 2024Rauch H, Kitzberger C, Janghu K, Hawarihewa P, Nguyen NT, Min Y, Ballke S, Steiger K, Weber WA, Kossatz S.dark environment. In the blocking group, cells were incubated with 25 µM octreotide (MedChemExpress, #HY-17365) for 15 min at 4 °C, followed 0.25 µM Fluo-Oct for 15 min in the dark. Then, cells were stained with

(3) Octreotide attenuates intestinal barrier damage by maintaining basal autophagy in Caco2 cellsMolecular Medicine ReportsApril 3, 2024Xiaoli Liu, Yan Zhou, Yu Zhang, Xigang Cui, Donglin Yang, Yuling Limedium with a final concentration of 100, 50, 10, 1 and 0.1 µg/ml for different durations. OCT (cat. no. HY-17365; MedChemExpress) with a final concentration of 10, 20 or 50 µM was added to the corresponding culture

(4) Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotineNature communicationsFebruary 21, 2023Zhao J, Fu H, Yu J, Hong W, Tian X, Qi J, Sun S, Zhao C, Wu C, Xu Z, et al.expression of SSTR wild-type and mutants” as described in the last paragraph41, except that octreotide (MCE, HY-17365) or paltusotine (MCE, HY-109155) need to be added and incubated at 37 °C for 30 min before being fixed

(5) Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotideJournal of controlled release : official journal of the Controlled Release SocietyMay 28, 2016Wang M, Shan F, Zou Y, Sun X, Zhang ZR, Fu Y, Gong T.

(6) Treatment of Gastrin-Secreting Tumor With Sustained-Release Octreotide Acetate in a DogJournal of the American Animal Hospital AssociationNovember 1, 2015Kim S, Hosoya K, Takagi S, Okumura M.

(7) Epidemiological research design: utility for the occupational health nurseOccupational health nursingApril 1, 1982Morse JM.

Be the First to Write a Review!

Octreotide acetate from MedChemExpress

Description

MedChemExpress

Citations (7)

Reviews

Octreotide acetate from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map